SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-035691
Filing Date
2020-11-09
Accepted
2020-11-09 06:10:54
Documents
5
Period of Report
2020-11-09

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea129529-6k_immuron.htm 6-K 13161
2 US DOD NMRC REPORTS POSITIVE RESPONSE TO VACCINE ea129529ex99-1_immuron.htm EX-99.1 27725
3 GRAPHIC image_001.jpg GRAPHIC 2985
4 GRAPHIC ex99-1_001.jpg GRAPHIC 10619
5 GRAPHIC ex99-1_002.jpg GRAPHIC 2685
  Complete submission text file 0001213900-20-035691.txt   64750
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 201295985
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences